Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

IBRX

ImmunityBio, Inc.

Healthcare · USD

Set alert

Price alert · IBRX

All alert types
8.29 USD -0.45 -5.15%
As of Oct 30, 2026 Extended hours 8.29 0.00%
Bid
8.28 × 2
Ask
8.29 × 26
8.12 Day range 8.72
1.98 52-week range 11.55
YTD
+318.69%
1 year
+251.27%
Open
8.48
Prev close
8.74
Mkt cap
8.79B
Vol
8.96M
Avg vol
11.49M
EPS
-0.96
P/E
0.00
Div yield
0.00%
More statistics
Low
8.12
High
8.72
Forward P/E
-113.05
Beta
0.03
Short ratio
7.96
Inst. own
19.80%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
8.70
200-d avg
7.88
1y target
14.25

5D chart

Chart tools
Interval
1m5m15m30m
IBRX five-day price chart7.758.058.348.648.94Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-10.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -5.2×
FY 2016: -15.5×FY 2017: -15.0×FY 2018: -3.9×FY 2019: -9.0×FY 2020: -22.6×FY 2021: -6.8×FY 2022: -4.9×FY 2023: -4.4×FY 2024: -4.3×FY 2025: -5.2×
FY 2016 5y median -4.9× FY 2025
P/S 16.1×
FY 2016: 42712×FY 2017: 31544×FY 2018: 8022×FY 2019: 33773×FY 2020: 8443×FY 2021: 2534×FY 2022: 8448×FY 2023: 4105×FY 2024: 121×FY 2025: 16.1×
FY 2016 5y median 2534× FY 2025
P/B -3.6×
FY 2016: 6.4×FY 2017: 6.5×FY 2018: 2.6×FY 2019: 12.0×FY 2020: -42.6×FY 2021: -9.8×FY 2022: -4.5×FY 2023: -4.3×FY 2024: -3.6×FY 2025: -3.6×
FY 2016 5y median -4.3× FY 2025
P/FCF -5.9×
FY 2016: -41.6×FY 2017: -17.0×FY 2018: -4.9×FY 2019: -9.3×FY 2020: -29.5×FY 2021: -7.7×FY 2022: -4.9×FY 2023: -6.4×FY 2024: -4.5×FY 2025: -5.9×
FY 2016 5y median -5.9× FY 2025
EV/EBITDA -11.7×
FY 2016: -16.0×FY 2017: -15.5×FY 2018: -4.2×FY 2019: -28.0×FY 2020: -26.2×FY 2021: -8.8×FY 2022: -7.5×FY 2023: -6.3×FY 2024: -8.1×FY 2025: -11.7×
FY 2016 5y median -8.1× FY 2025
EV/Sales 23.0×
FY 2016: 42715×FY 2017: 31175×FY 2018: 7812×FY 2019: 33758×FY 2020: 8840×FY 2021: 3031×FY 2022: 11028×FY 2023: 4847×FY 2024: 146×FY 2025: 23.0×
FY 2016 5y median 3031× FY 2025
FCF Yield -17.0%
FY 2016: -2.4%FY 2017: -5.9%FY 2018: -20.3%FY 2019: -10.8%FY 2020: -3.4%FY 2021: -13.0%FY 2022: -20.5%FY 2023: -15.6%FY 2024: -22.3%FY 2025: -17.0%
FY 2016 5y median -17.0% FY 2025

Profitability

Gross Margin 99.3%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 6717.0%FY 2019: -20858.1%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 99.3%
FY 2016 5y median 100.0% FY 2025
Operating Margin -226.0%
FY 2016: -282954.5%FY 2017: -220266.7%FY 2018: -209338.3%FY 2019: -155597.7%FY 2020: -36509.1%FY 2021: -35361.9%FY 2022: -146374.2%FY 2023: -58239.5%FY 2024: -2334.2%FY 2025: -226.0%
FY 2016 5y median -35361.9% FY 2025
Net Margin -310.2%
FY 2016: -274565.9%FY 2017: -214273.3%FY 2018: -204736.2%FY 2019: -152997.7%FY 2020: -36669.6%FY 2021: -37129.6%FY 2022: -173569.6%FY 2023: -93761.4%FY 2024: -2804.8%FY 2025: -310.2%
FY 2016 5y median -37129.6% FY 2025
ROE 70.3%
FY 2016: -41.2%FY 2017: -44.1%FY 2018: -65.9%FY 2019: -54.5%FY 2020: 185.2%FY 2021: 143.2%FY 2022: 93.1%FY 2023: 99.4%FY 2024: 84.6%FY 2025: 70.3%
FY 2016 5y median 93.1% FY 2025
ROIC -56.9%
FY 2016: -40.6%FY 2017: -42.8%FY 2018: -62.9%FY 2019: -49.3%FY 2020: -138.4%FY 2021: -82.1%FY 2022: -118.7%FY 2023: -80.2%FY 2024: -102.6%FY 2025: -56.9%
FY 2016 5y median -82.1% FY 2025
ROA -70.0%
FY 2016: -38.1%FY 2017: -38.5%FY 2018: -52.9%FY 2019: -46.0%FY 2020: -100.2%FY 2021: -74.0%FY 2022: -115.0%FY 2023: -115.6%FY 2024: -108.0%FY 2025: -70.0%
FY 2016 5y median -108.0% FY 2025

Growth (YoY)

Revenue 668.3%
FY 2016: -81.4%FY 2017: 2.3%FY 2018: 4.4%FY 2019: -8.5%FY 2020: 1307.0%FY 2021: 54.4%FY 2022: -74.3%FY 2023: 159.2%FY 2024: 2270.6%FY 2025: 668.3%
FY 2016 FY 2025
Operating Income 25.6%
FY 2016: 47.9%FY 2017: 20.4%FY 2018: 0.7%FY 2019: 32.0%FY 2020: -230.1%FY 2021: -49.5%FY 2022: -6.4%FY 2023: -3.1%FY 2024: 5.0%FY 2025: 25.6%
FY 2016 FY 2025
EPS (diluted) 38.7%
FY 2016: 49.3%FY 2017: 18.9%FY 2018: 0.0%FY 2019: -40.0%FY 2020: -40.5%FY 2021: -50.8%FY 2022: -16.9%FY 2023: -10.6%FY 2024: 46.1%FY 2025: 38.7%
FY 2016 FY 2025
Free Cash Flow 22.4%
FY 2016: -63.9%FY 2017: -85.1%FY 2018: 8.5%FY 2019: -104.5%FY 2020: -10.9%FY 2021: -77.6%FY 2022: -35.0%FY 2023: 4.4%FY 2024: -0.2%FY 2025: 22.4%
FY 2016 FY 2025

Financial Health

Current Ratio 5.1×
FY 2016: 16.3×FY 2017: 6.3×FY 2018: 3.3×FY 2019: 4.8×FY 2020: 1.6×FY 2021: 0.9×FY 2022: 0.3×FY 2023: 5.0×FY 2024: 3.4×FY 2025: 5.1×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 5.1×
FY 2016: 16.3×FY 2017: 6.3×FY 2018: 3.3×FY 2019: 4.8×FY 2020: 1.6×FY 2021: 0.9×FY 2022: 0.3×FY 2023: 5.0×FY 2024: 3.2×FY 2025: 5.1×
FY 2016 5y median 3.2× FY 2025
Debt / Equity -1.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: -2.3×FY 2021: -2.7×FY 2022: -1.6×FY 2023: -1.2×FY 2024: -1.0×FY 2025: -1.8×
FY 2016 5y median -1.6× FY 2025
Net Debt / EBITDA -3.5×
FY 2016: -0.0×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.0×FY 2020: -1.2×FY 2021: -1.4×FY 2022: -1.8×FY 2023: -1.0×FY 2024: -1.4×FY 2025: -3.5×
FY 2016 5y median -1.4× FY 2025
Interest Coverage -2.3×
FY 2016: -1886×FY 2017: -160×FY 2018: -227×FY 2019: -11.3×FY 2020: -24.3×FY 2021: -22.2×FY 2022: -7.5×FY 2023: -4.2×FY 2024: -2.6×FY 2025: -2.3×
FY 2016 5y median -4.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31